Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

638 recalls, newest first

Class III · Low risk

buPROPion Hydrochloride Extended-Release Tablet

Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle.

Terminated Particulate / foreign matter Sun Pharmaceutical Industries INC D-0857-2022
Class II · Moderate risk

Glycopyrrolate Tablets

Presence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room.

Terminated Particulate / foreign matter Aurolife Pharma, LLC NDC 13107-014-01 D-0736-2022
Class I · High risk

Sodium Acetate Injection

Presence of particulate matter: particulates composed of carbon and oxygen with varying amounts of iron and trace amounts of sodium, silicon, chromium, aluminum and cellulose.

Terminated Particulate / foreign matter Fresenius Kabi USA, LLC NDC 63323-032-00 D-0750-2022
Class II · Moderate risk

Chlorthalidone Tablets USP 25 mg

Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup

Terminated Particulate / foreign matter Sun Pharmaceutical Industries INC NDC 57664-648-88 D-0578-2022
Class I · High risk

Veklury (remdesivir)

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Terminated Particulate / foreign matter Gilead Sciences, Inc. NDC 61958-2901-2 D-0299-2022
Class II · Moderate risk

Ezetimibe and Simvastatin Tablets

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Terminated Particulate / foreign matter Golden State Medical Supply Inc. D-0227-2022
Class II · Moderate risk

Dr. Reddy's Ezetimibe and Simvastatin Tablets

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Terminated Particulate / foreign matter Dr. Reddy's Laboratories, Inc. NDC 43598-743-05 D-0085-2022
Class II · Moderate risk

Carvedilol Tablets

Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle

Terminated Particulate / foreign matter Zydus Pharmaceuticals (USA) Inc NDC 68382-095-05 D-0753-2021
Class I · High risk

Topotecan Injection 4 mg/4mL

Presence of Particulate Matter: Complaint received of a glass particle observed inside the vial. The vial was returned to Teva for further analysis where two other particulates were found and identified as one (1) grey silicone particle and one (1) translucent, colorless cotton fiber.

Terminated Particulate / foreign matter Teva Pharmaceuticals USA NDC 0703-4714-01 D-0661-2021
Class II · Moderate risk

DermOtic Oil

Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper.

Terminated Particulate / foreign matter Hill Dermaceuticals, Inc. NDC 68791-103-20 D-0637-2021

Recalls by year